USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NanoValent Pharmaceuticals, Inc.
Address:
910 Technology BLVD STE G
Bozeman, MT 59718-4012
Phone:
N/A
URL:
N/A
EIN:
205342640
DUNS:
788166986
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
Yes

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $149,848.00 1
SBIR Phase II $300,000.00 1

Award List:

SBIR Phase I: Targeted Nanoparticle Delivery Agent for Treatment of Adult Leukemia

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$149,848.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project aims to explore the application of a targeted nanodelivery system for both treatment and efficacy monitoring in patients with adult leukemia. Unlike solid tumors, for which surgery, radiation, and conventional treatments are an option,… More

SBIR Phase II: Targeted Nanoparticle Delivery Agent for Treatment of Adult Leukemia

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$300,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase II project will develop targeted nanoparticle delivery systems capable of delivering conventional cytotoxics preferentially to tumor cells. While therapeutic nanoparticles have been introduced into clinical practice (Abraxane(TM) and Doxil(TM)) and… More